Drugs / GSK523338
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT00256867 | Aug 2005 → Oct 2006 | type 2 diabetes mellitus | GlaxoSmithKline | Completed | Met primary |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | GSK523338 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00256867 ↗ |